Literature DB >> 10481102

Lack of expression of bundle-forming pili in some clinical isolates of enteropathogenic Escherichia coli (EPEC) is due to a conserved large deletion in the bfp operon.

M R Bortolini1, L R Trabulsi, R Keller, G Frankel, V Sperandio.   

Abstract

Enteropathogenic Escherichia coli (EPEC) produces a plasmid-encoded type IV pilus, called the bundle-forming pilus (BFP), involved in the formation of the localized adhesion onto epithelial cells. In this study, we demonstrate that clinical isolates of serotypes O128ab:H2 and O119:H2 contain a ca. 13-kb deletion in the bfp operon, resulting in a lack of expression of these pili. An IS sequence with homology to the IS66 of Agrobacterium tumefaciens replaced the deleted bfp genes. These results suggest that the bfp operon was deleted through a transpositional event and that other adherence factors may mediate attachment of these bacteria to the host cells.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10481102     DOI: 10.1111/j.1574-6968.1999.tb08723.x

Source DB:  PubMed          Journal:  FEMS Microbiol Lett        ISSN: 0378-1097            Impact factor:   2.742


  14 in total

1.  Expression of the bundle-forming pilus by enteropathogenic Escherichia coli strains of heterologous serotypes.

Authors:  Juana Gismero-Ordoñez; Monique Dall'Agnol; Luiz R Trabulsi; Jorge A Girón
Journal:  J Clin Microbiol       Date:  2002-06       Impact factor: 5.948

2.  A second large plasmid encodes conjugative transfer and antimicrobial resistance in O119:H2 and some typical O111 enteropathogenic Escherichia coli strains.

Authors:  Adaobi I Nwaneshiudu; Tania Mucci; Derek J Pickard; Iruka N Okeke
Journal:  J Bacteriol       Date:  2007-06-15       Impact factor: 3.490

3.  Relationship between the Tsh autotransporter and pathogenicity of avian Escherichia coli and localization and analysis of the Tsh genetic region.

Authors:  C M Dozois; M Dho-Moulin; A Brée; J M Fairbrother; C Desautels; R Curtiss
Journal:  Infect Immun       Date:  2000-07       Impact factor: 3.441

4.  Comparative sequence analysis of the plasmid-encoded regulator of enteropathogenic Escherichia coli Strains.

Authors:  I N Okeke; J A Borneman; S Shin; J L Mellies; L E Quinn; J B Kaper
Journal:  Infect Immun       Date:  2001-09       Impact factor: 3.441

5.  Molecular variation among type IV pilin (bfpA) genes from diverse enteropathogenic Escherichia coli strains.

Authors:  T E Blank; H Zhong; A L Bell; T S Whittam; M S Donnenberg
Journal:  Infect Immun       Date:  2000-12       Impact factor: 3.441

Review 6.  Recent advances in understanding enteric pathogenic Escherichia coli.

Authors:  Matthew A Croxen; Robyn J Law; Roland Scholz; Kristie M Keeney; Marta Wlodarska; B Brett Finlay
Journal:  Clin Microbiol Rev       Date:  2013-10       Impact factor: 26.132

7.  Characterization of atypical enteropathogenic Escherichia coli strains harboring the astA gene that were associated with a waterborne outbreak of diarrhea in Japan.

Authors:  Jun Yatsuyanagi; Shioko Saito; Yoshimichi Miyajima; Ken-Ichi Amano; Katsuhiko Enomoto
Journal:  J Clin Microbiol       Date:  2003-05       Impact factor: 5.948

8.  Comparative Genomics Provides Insight into the Diversity of the Attaching and Effacing Escherichia coli Virulence Plasmids.

Authors:  Tracy H Hazen; James B Kaper; James P Nataro; David A Rasko
Journal:  Infect Immun       Date:  2015-08-03       Impact factor: 3.441

9.  Clonal relationship among atypical enteropathogenic Escherichia coli strains isolated from different animal species and humans.

Authors:  Rodrigo A Moura; Marcelo P Sircili; Luciana Leomil; Maria Helena Matté; Luiz R Trabulsi; Waldir P Elias; Kinue Irino; Antonio F Pestana de Castro
Journal:  Appl Environ Microbiol       Date:  2009-10-02       Impact factor: 4.792

10.  Genetic elements associated with antimicrobial resistance in enteropathogenic Escherichia coli (EPEC) from Brazil.

Authors:  Isabel C A Scaletsky; Tamara B Souza; Katia R S Aranda; Iruka N Okeke
Journal:  BMC Microbiol       Date:  2010-01-27       Impact factor: 3.605

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.